EIX vs TBPH · P/E 7.3, rev $19.32B vs P/E 7.5, rev $38.4M
Edison International (EIX) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the EIX and TBPH stock pages for the full models.
Not investment advice.